Scientist.com DataSmart Blockchain For Biopharmaceutical Clinical Data Security
During the last decade, Scientist.com has been connecting buyers and sellers of research services. With the exchange, they are able to deliver faster science through an innovative approach to research and development.
But it may be sometimes difficult to have search and find the correct sources for scientific investigations. And that’s what Scientist changes, it allows suppliers, researchers and enterprises interact and have the information they need to keep their innovative processes. The main mission is to empower and connect researchers worldwide
With Scientist you are able to find the best resources that will allow you to support your studies surrounding human biological samples, biomarkers, immunotherapy, protein engineering and more.
For researchers, it helps them saving time and reducing costs. They can have access to the latest tools from academic labs and industry-leading CROs. Scientist.com connects suppliers to the world’s largest pharma companies and the long tail of biotech and academic customers.
Scientist not only works for suppliers and researchers, but also for enterprises. It allows them to have access to private marketplaces that simplify the purchase of research services. That makes the overall experience for enterprises more efficient, and improves access to innovation and ensuring compliance.
Scientist.com is managed by a group of experts in different scientific areas, ranging from the pharmaceutical industry to lifesciences.
Kevin Lustig is the CEO and President. He has over 30 years of research experience in academia and pharma.
Christopher Petersen is the CTO. He is a software engineer who has worked extensively with drug researchers in order to develop online solutions to complex scientific processes.
Daniel Kagan is the COO of Scientist.com. He is a bioengineer that worked extensively with life science start-up companies.
Inge Bear is the Chief Development Officer. She is a clinical trialist with nearly 30 years of experience in the biopharmaceutical industry, with cross-functional leadership in drug development from IND-enabling studies through NDA filings.
Arne Brandon is the Chief Commercial Officer. He is a respected leader with more than 30 years of history of consistently delivering growth rates above market levels.